BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Falchetti M, Delgobo M, Zancanaro H, Almeida K, das Neves RN, Dos Santos B, Stefanes NM, Bishop A, Santos-Silva MC, Zanotto-Filho A. Omics-based identification of an NRF2-related auranofin resistance signature in cancer: Insights into drug repurposing. Comput Biol Med 2023;152:106347. [PMID: 36493734 DOI: 10.1016/j.compbiomed.2022.106347] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Kim HY, Otgontenger U, Kim JW, Lee YJ, Kim SB, Lim SC, Kim YM, Kang KW. Anti-fibrotic effect of aurocyanide, the active metabolite of auranofin. Arch Pharm Res 2023;46:149-59. [PMID: 36894745 DOI: 10.1007/s12272-023-01438-1] [Reference Citation Analysis]
2 Samarin J, Fabrowski P, Kurilov R, Nuskova H, Hummel-Eisenbeiss J, Pink H, Li N, Weru V, Alborzinia H, Yildiz U, Grob L, Taubert M, Czech M, Morgen M, Brandstädter C, Becker K, Mao L, Jayavelu AK, Goncalves A, Uhrig U, Seiler J, Lyu Y, Diederichs S, Klingmüller U, Muckenthaler M, Kopp-Schneider A, Teleman A, Miller AK, Gunkel N. Low level of antioxidant capacity biomarkers but not target overexpression predicts vulnerability to ROS-inducing drugs. Redox Biol 2023;62:102639. [PMID: 36958250 DOI: 10.1016/j.redox.2023.102639] [Reference Citation Analysis]
3 Yang R, Sun S, Guo Y, Meng Y, Liu H, Shi M, Guan S, Xu J. Anti-Inflammatory Effect of Dimethyl Fumarate Associates with the Inhibition of Thioredoxin Reductase 1 in RAW 264.7 Cells. Molecules 2022;28. [PMID: 36615301 DOI: 10.3390/molecules28010107] [Reference Citation Analysis]